Western Health Advantage
Truseltiq (50MG Daily Dose) (infigratinib)
Drugs for Cancer : Drugs for Cancer
  • Quantity Limit: limit maximum 120 EA PER 30 day(s)
  • Quantity Limit: limit maximum 8 EA PER 30 day(s)
  • Hemophilia A (Factor VIII):
    Duration: 1 year(s)
    Documented Diagnosis: No
    Medical Test Required: No
    Reauthorization Required: No
    Duration of Reauthorization: N/A
    Dosing Limit(s): N/A
    Treatment Center Required: No

  • Prior Authorization: Anxiety:
    Duration: 1 year(s)